LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

Search

Assertio Holdings Inc

Затворен

0.79 -1.25

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.79

Максимум

0.8

Ключови измерители

By Trading Economics

Приходи

-2.8M

-16M

Продажби

2.7M

29M

Марж на печалбата

-55.958

Служители

58

EBITDA

6.9M

-6.4M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+208.64% upside

Дивиденти

By Dow Jones

Следващи печалби

10.11.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

8M

77M

Предишно отваряне

2.04

Предишно затваряне

0.79

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

Assertio Holdings Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.09.2025 г., 22:39 ч. UTC

Придобивния, сливания и поглъщания

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15.09.2025 г., 16:43 ч. UTC

Значими двигатели на пазара

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15.09.2025 г., 16:42 ч. UTC

Значими двигатели на пазара

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15.09.2025 г., 16:35 ч. UTC

Значими двигатели на пазара

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15.09.2025 г., 23:46 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

15.09.2025 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15.09.2025 г., 23:34 ч. UTC

Пазарно говорене

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15.09.2025 г., 22:48 ч. UTC

Пазарно говорене

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15.09.2025 г., 22:12 ч. UTC

Придобивния, сливания и поглъщания

CSL Expects Commercial Launch in 2029

15.09.2025 г., 22:12 ч. UTC

Придобивния, сливания и поглъщания

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15.09.2025 г., 22:11 ч. UTC

Придобивния, сливания и поглъщания

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15.09.2025 г., 22:11 ч. UTC

Придобивния, сливания и поглъщания

CSL to Have Right to Exercise Option Based on Phase 3 Data

15.09.2025 г., 22:10 ч. UTC

Придобивния, сливания и поглъщания

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15.09.2025 г., 21:16 ч. UTC

Придобивния, сливания и поглъщания

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15.09.2025 г., 21:16 ч. UTC

Придобивния, сливания и поглъщания

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15.09.2025 г., 21:15 ч. UTC

Придобивния, сливания и поглъщания

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15.09.2025 г., 21:14 ч. UTC

Придобивния, сливания и поглъщания

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

15.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

15.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

15.09.2025 г., 19:29 ч. UTC

Пазарно говорене

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15.09.2025 г., 19:14 ч. UTC

Пазарно говорене

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15.09.2025 г., 18:16 ч. UTC

Пазарно говорене

Gold Powers to New High -- Market Talk

15.09.2025 г., 18:05 ч. UTC

Пазарно говорене

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15.09.2025 г., 17:50 ч. UTC

Придобивния, сливания и поглъщания

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15.09.2025 г., 17:10 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

15.09.2025 г., 17:10 ч. UTC

Пазарно говорене

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15.09.2025 г., 16:52 ч. UTC

Пазарно говорене

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15.09.2025 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

15.09.2025 г., 16:20 ч. UTC

Пазарно говорене
Печалби

Auto & Transport Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Assertio Holdings Inc Прогноза

Ценова цел

By TipRanks

208.64% нагоре

12-месечна прогноза

Среден 2.5 USD  208.64%

Висок 3 USD

Нисък 1 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Assertio Holdings Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

4 ratings

3

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

0.618 / 0.649Подкрепа & съпротива

Краткосрочен план

Strong Bullish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Weak Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Assertio Holdings Inc

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.
help-icon Live chat